This will be a randomised, single-centre, single-blind, parallel-group, pilot study in
patients undergoing colonoscopy.
The primary objective is to evaluate the efficacy of MOVIPREP® versus PICOLAX® for gut
cleansing prior to colonoscopy.
The secondary objectives are to evaluate the safety, tolerability and acceptability of
MOVIPREP versus PICOLAX for gut cleansing prior to colonoscopy.
The aim of the study is to compare a new 2 litre bowel cleansing product versus a sodium
phosphate solution already on the market. Efficacy of each bowel preparation, safety and
acceptability will be assessed.
A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution
Completed
Norgine
Phase 3
2002-06-01
The study was carried out as a randomised, single-blind, active-controlled, multi-centric,
phase III study with two parallel treatment groups. The primary efficacy criterion was the
frequency of effective gut cleansing in each of the two treatment groups (grade A or B
"overall quality of gut cleansing" as judged by a blinded expert panel on the basis of
videotapes recorded during the endoscopic procedure).
Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening
Completed
Norgine
Phase 3
2004-09-01
To compare the efficacy, acceptability and safety of the new 2 liter gut cleansing solution
(Moviprep) and NaP preparation in routine colon cleansing prior to tumor screening
colonoscopies
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
